Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
J Exp Med ; 218(12)2021 12 06.
Article in English | MEDLINE | ID: mdl-34709349

ABSTRACT

Group 2 innate lymphoid cells (ILC2s) are unique in their ability to produce low levels of type 2 cytokines at steady state, and their production capacity is dramatically increased upon stimulation with IL-33. However, it is unknown how constitutive cytokine production is regulated in the steady state. Here, we found that tristetraprolin (TTP/Zfp36), an RNA-binding protein that induces mRNA degradation, was highly expressed in naive ILC2s and was downregulated following IL-33 stimulation. In ILC2s from Zfp36-/- mice, constitutive IL-5 production was elevated owing to the stabilization of its mRNA and resulted in an increased number of eosinophils in the intestine. Luciferase assay demonstrated that TTP directly regulates Il5 mRNA stability, and overexpression of TTP markedly suppressed IL-5 production by ILC2s, even under IL-33 stimulation. Collectively, TTP-mediated posttranscriptional regulation acts as a deterrent of excessive cytokine production in steady-state ILC2s to maintain body homeostasis, and downregulation of TTP may contribute to massive cytokine production under IL-33 stimulation.


Subject(s)
Lymphocytes/physiology , Tristetraprolin/metabolism , Animals , Cytokines/metabolism , DNA-Binding Proteins/genetics , Female , Homeostasis , Immunity, Innate , Interleukin Receptor Common gamma Subunit/genetics , Interleukin-13/genetics , Interleukin-13/metabolism , Interleukin-33/genetics , Interleukin-33/metabolism , Interleukin-5/genetics , Interleukin-5/metabolism , Mice, Inbred C57BL , Mice, Mutant Strains , RNA Processing, Post-Transcriptional , RNA, Messenger/metabolism , Tristetraprolin/genetics
2.
Eur Respir J ; 57(3)2021 03.
Article in English | MEDLINE | ID: mdl-32978308

ABSTRACT

Regnase-1 is an RNase critical for post-transcriptional control of pulmonary immune homeostasis in mice by degrading immune-related mRNAs. However, little is known about the cell types Regnase-1 controls in the lung, and its relevance to human pulmonary diseases.Regnase-1-dependent changes in lung immune cell types were examined by a competitive bone marrow transfer mouse model, and group 2 innate lymphoid cells (ILC2s) were identified. Then the associations between Regnase-1 in ILC2s and human diseases were investigated by transcriptome analysis and a bleomycin-induced pulmonary fibrosis mouse model. The clinical significance of Regnase-1 in ILC2s was further assessed using patient-derived cells.Regnase-1-deficiency resulted in the spontaneous proliferation and activation of ILC2s in the lung. Intriguingly, genes associated with pulmonary fibrosis were highly upregulated in Regnase-1-deficient ILC2s compared with wild-type, and supplementation of Regnase-1-deficient ILC2s augmented bleomycin-induced pulmonary fibrosis in mice. Regnase-1 suppresses mRNAs encoding transcription factors Gata3 and Egr1, which are potent to regulate fibrosis-associated genes. Clinically, Regnase-1 protein levels in ILC2 negatively correlated with the ILC2 population in bronchoalveolar lavage fluid. Furthermore, idiopathic pulmonary fibrosis (IPF) patients with ILC2s >1500 cells·mL-1 peripheral blood exhibited poorer prognosis than patients with lower numbers, implying the contribution of Regnase-1 in ILC2s for the progression of IPF.Collectively, Regnase-1 was identified as a critical post-transcriptional regulator of the profibrotic function of ILC2s both in mouse and human, suggesting that Regnase-1 may be a novel therapeutic target for IPF.


Subject(s)
Lymphocytes , Pulmonary Fibrosis , Animals , Bronchoalveolar Lavage Fluid , Humans , Immunity, Innate , Lung , Mice , Mice, Knockout , Pulmonary Fibrosis/chemically induced
3.
Biofabrication ; 8(3): 035006, 2016 07 26.
Article in English | MEDLINE | ID: mdl-27458788

ABSTRACT

Creation of cell micropatterns comprising heterogeneous cell populations is an important technique for tissue engineering, medical transplantation, drug discovery, and regenerative medicine. This paper presents a novel gel patterning technique similar to general micromachining for creating cell micropatterns using alginate gel to inhibit cell adhesion. The alginate thin-film micropattern was formed on a glass plate by photolithography and wet etching. Cell micropatterns were subsequently created along the alginate micropattern on the glass plate. This technique permits the creation of cell micropatterns with arbitrary geometry because hydrogel materials promoting or inhibiting cell adhesion can be patterned precisely. Moreover, this technique permits processing of the culture surface during cultivation because none of the materials used such as hydrogels and hydrogel-etching solutions exhibit cytotoxicity. A cell micropattern comprising different cell types was successfully created using the presented technique. This technique will be conducive to further improvement of the fabrication of artificial tissues formed by heterogeneous cells.


Subject(s)
Hydrogels/chemistry , Microtechnology/methods , Alginates/chemistry , Alginates/pharmacology , Animals , Cell Adhesion/drug effects , Cell Culture Techniques , Cell Line , Cell Proliferation/drug effects , Glucuronic Acid/chemistry , Glucuronic Acid/pharmacology , Hexuronic Acids/chemistry , Hexuronic Acids/pharmacology , Hydrogels/pharmacology , Surface Properties , Time-Lapse Imaging
SELECTION OF CITATIONS
SEARCH DETAIL